TARSUS PHARMACEUTICALS, INC. (TARS) Net income 2018–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$66.0MFY2025 · since FY2018: -$1.3M → -$66.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$66.0M | +43.1% |
| FY2024 | -$116.0M | +14.7% |
| FY2023 | -$136.0M | -119.0% |
| FY2022 | -$62.1M | -349.1% |
| FY2021 | -$13.8M | +48.4% |
| FY2020 | -$26.8M | -474.1% |
| FY2019 | -$4.7M | -254.1% |
| FY2018 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice